<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04173676</url>
  </required_header>
  <id_info>
    <org_study_id>No.ZDWY[2018]LunziNo.(K31-1)</org_study_id>
    <nct_id>NCT04173676</nct_id>
  </id_info>
  <brief_title>Sentinel Lymph Node Navigation Surgery Using Near-infrared Imaging in Early Esophageal Cancer</brief_title>
  <official_title>Sentinel Lymph Node Navigation Using Near-infrared Imaging in Radical Esophagectomy Surgery ：a Single-arm Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fifth Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fifth Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The esophageal squamous cell carcinoma (ESCC) has high prevalence and mortality in China,&#xD;
      which become a severe challenge for public health. Esophagectomy is the preferred choice for&#xD;
      the patients who are diagnosed with ESCC in early stage .Although three-field lymphadenectomy&#xD;
      has improved patient survival and reduced tumor recurrence, Surgery-related complications&#xD;
      increased dramatically.&#xD;
&#xD;
      It has become a research hotspot to find an effective detection method to identify the lymph&#xD;
      node metastasis of ESCC and avoid ineffective expanded lymphadenectomy .The molecular imaging&#xD;
      technology has been developed for intra-operative visualization and precise resection of the&#xD;
      tumors.&#xD;
&#xD;
      Indocyanine Green for Injection (ICG) has been used as a contrast agent in the near-infrared&#xD;
      imaging system for the surgical navigation technology, which has a relatively positive effect&#xD;
      in the clinical application of gastric cancer and liver cancer.There are few reports on the&#xD;
      application of ICG near-infrared imaging tracer lymph nodes in the surgery of ESCC. This&#xD;
      study intends to identify the detection rate of sentinel lymph node (SLN) and determine the&#xD;
      accuracy of regional lymph node metastasis in ESCC by ICG near-infrared imaging technique,&#xD;
      which provides clinical evidence for subsequent precise resection of the lymph nodes.&#xD;
&#xD;
      This will be one-arm prospective trial. The ESCC patients will be recruited with strict&#xD;
      criteria. 84 patients will be enrolled between18 and 75 years old, without gender limit. The&#xD;
      submucosal injection of ICG will be performed preoperatively by gastroscopy on the superior&#xD;
      and inferior edge of the esophageal tumor. NIR fluorescence imaging will be performed&#xD;
      intraoperatively to observe the lymph nodes. The luminescent lymph node is defined as SLN.&#xD;
      According to the standard procedure, 3 field lymphadenectomy will be performed, and all the&#xD;
      resected lymph nodes will be subjected to pathological analysis including correlation study&#xD;
      of fluorescence signal and tumor tissue in pathology slice.&#xD;
&#xD;
      This clinical trial is anticipated to evaluate the detection rate of SLN in ESCC with ICG&#xD;
      near-infrared fluorescence imaging and determine the accuracy of regional lymph node&#xD;
      metastasis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The sentinel lymph nodes are observed by submucosal injection of ICG</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the detection rate of sentinel lymph node</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>the detection rate of sentinel lymph node in all the enrolled patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The positive rate of sentinel lymph node</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>the positive rate of sentinel lymph node in all the enrolled patients</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Detection Rate of SLN ; Accuracy Rate of Lymph Node Metastasis</condition>
  <arm_group>
    <arm_group_label>use of indocyanine green</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>submucosal injection of ICG is by gastroscopy on the superior and inferior edge of the esophageal tumor,Dose of 0.5mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indocyanine Green for Injection</intervention_name>
    <description>The sentinel lymph nodes were observed by submucosal injection of ICG</description>
    <arm_group_label>use of indocyanine green</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18 years old ≤ age ≤ 75 years old, gender is not limited;&#xD;
&#xD;
          2. patient who is diagnosed with ESCC and choose to proceed with surgery&#xD;
&#xD;
          3. patient with cTNM stage:T1-3N0-1M0&#xD;
&#xD;
          4. tumor located at the middle thoracic or lower thoracic esophagus&#xD;
&#xD;
          5. The main organ function is basically normal: Karnofsky score &gt;70%;&#xD;
&#xD;
          6. Laboratory blood tests meet surgical standards;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. pregnancy or breastfeeding&#xD;
&#xD;
          2. history of iodide or seafood allergy,&#xD;
&#xD;
          3. Patient with occult metastatic disease at the time of surgery&#xD;
&#xD;
          4. patient with mental disorder;&#xD;
&#xD;
          5. Patient who is simultaneously involved in another clinical trial;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hong Shan, PhD</last_name>
    <phone>+86-18826913336</phone>
    <email>shanhong@mail.sysu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Fifth Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Zhuhai</city>
        <state>Guangdong</state>
        <zip>519000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaojin Wang, MD</last_name>
      <phone>+86-13798967219</phone>
      <email>wangxj55@mail.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Shirakawa S, Toyama H, Kido M, Fukumoto T. A prospective single-center protocol for using near-infrared fluorescence imaging with indocyanine green during staging laparoscopy to detect small metastasis from pancreatic cancer. BMC Surg. 2019 Nov 7;19(1):165. doi: 10.1186/s12893-019-0635-0.</citation>
    <PMID>31699083</PMID>
  </results_reference>
  <results_reference>
    <citation>Lim HJ, Chiow AKH, Lee LS, Tan SS, Goh BK, Koh YX, Chan CY, Lee SY. Novel method of intraoperative liver tumour localisation with indocyanine green and near-infrared imaging. Singapore Med J. 2021 Apr;62(4):182-189. doi: 10.11622/smedj.2019137. Epub 2019 Nov 4.</citation>
    <PMID>31680180</PMID>
  </results_reference>
  <results_reference>
    <citation>Yanagi Y, Yoshimaru K, Matsuura T, Shibui Y, Kohashi K, Takahashi Y, Obata S, Sozaki R, Izaki T, Taguchi T. The outcome of real-time evaluation of biliary flow using near-infrared fluorescence cholangiography with Indocyanine green in biliary atresia surgery. J Pediatr Surg. 2019 Dec;54(12):2574-2578. doi: 10.1016/j.jpedsurg.2019.08.029. Epub 2019 Sep 2.</citation>
    <PMID>31575415</PMID>
  </results_reference>
  <results_reference>
    <citation>Hayami S, Matsuda K, Iwamoto H, Ueno M, Kawai M, Hirono S, Okada K, Miyazawa M, Tamura K, Mitani Y, Kitahata Y, Mizumoto Y, Yamaue H. Visualization and quantification of anastomotic perfusion in colorectal surgery using near-infrared fluorescence. Tech Coloproctol. 2019 Oct;23(10):973-980. doi: 10.1007/s10151-019-02089-5. Epub 2019 Sep 18.</citation>
    <PMID>31535238</PMID>
  </results_reference>
  <results_reference>
    <citation>Zhou SC, Tian YT, Wang XW, Zhao CD, Ma S, Jiang J, Li EN, Zhou HT, Liu Q, Liang JW, Zhou ZX, Wang XS. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer. World J Gastroenterol. 2019 Aug 21;25(31):4502-4511. doi: 10.3748/wjg.v25.i31.4502.</citation>
    <PMID>31496628</PMID>
  </results_reference>
  <results_reference>
    <citation>Yamada Y, Ohno M, Fujino A, Kanamori Y, Irie R, Yoshioka T, Miyazaki O, Uchida H, Fukuda A, Sakamoto S, Kasahara M, Matsumoto K, Fuchimoto Y, Hoshino K, Kuroda T, Hishiki T. Fluorescence-Guided Surgery for Hepatoblastoma with Indocyanine Green. Cancers (Basel). 2019 Aug 20;11(8). pii: E1215. doi: 10.3390/cancers11081215. Review.</citation>
    <PMID>31434361</PMID>
  </results_reference>
  <results_reference>
    <citation>Predina JD, Newton AD, Corbett C, Shin M, Sulfyok LF, Okusanya OT, Delikatny EJ, Nie S, Gaughan C, Jarrar D, Pechet T, Kucharczuk JC, Singhal S. Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas. J Thorac Cardiovasc Surg. 2019 May;157(5):2061-2069. doi: 10.1016/j.jtcvs.2018.10.169. Epub 2018 Dec 14.</citation>
    <PMID>31288365</PMID>
  </results_reference>
  <results_reference>
    <citation>Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013 Feb 2;381(9864):400-12. doi: 10.1016/S0140-6736(12)60643-6. Review.</citation>
    <PMID>23374478</PMID>
  </results_reference>
  <results_reference>
    <citation>Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Blackstone EH. Worldwide Esophageal Cancer Collaboration: clinical staging data. Dis Esophagus. 2016 Oct;29(7):707-714. doi: 10.1111/dote.12493.</citation>
    <PMID>27731549</PMID>
  </results_reference>
  <results_reference>
    <citation>Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Ectors N. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004 Dec;240(6):962-72; discussion 972-4.</citation>
    <PMID>15570202</PMID>
  </results_reference>
  <results_reference>
    <citation>Taniyama Y, Nakamura T, Mitamura A, Teshima J, Katsura K, Abe S, Nakano T, Kamei T, Miyata G, Ouchi N. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg. 2013 Jun;95(6):1930-7. doi: 10.1016/j.athoracsur.2013.03.069. Epub 2013 May 1.</citation>
    <PMID>23642437</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>November 17, 2019</study_first_submitted>
  <study_first_submitted_qc>November 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2019</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphatic Metastasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

